StockData
Inhibrx Biosciences, Inc. logo

Inhibrx Biosciences, Inc. (INBX) stock

INBXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$69.06−5.12 (-6.90%)

Close on Nov 18, 2026Market cap $1.02BP/E –Yield –

Inhibrx Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Inhibrx Biosciences's price to sales ratio was 348.3× on Sep 30, 2025, against 334.4× a year earlier. Over the last 4 years it ranged from 13.6× to 390.0×, with a median of 50.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Sep 30, 2025348.3×+219.7
2024Dec 31, 2024128.6×−153.4
2023Oct 31, 2023281.9×+231.5
2022Dec 30, 202250.4×−7.5
2021Dec 31, 202157.9×+28.0
2020Dec 31, 202030.0×–

More Inhibrx Biosciences figures

See a number that looks wrong?